We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+13.09%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23.2B
AUM Growth
+$2.65B
Cap. Flow
+$745M
Cap. Flow %
3.21%
Top 10 Hldgs %
28.76%
Holding
1,586
New
30
Increased
559
Reduced
189
Closed
24

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$113M
2
AAPL icon
Apple
AAPL
+$86.8M
3
MSFT icon
Microsoft
MSFT
+$69.1M
4
BKNG icon
Booking.com
BKNG
+$67.4M
5
AMZN icon
Amazon
AMZN
+$66.2M

Top Sells

Rank Stock Value
1
DAR icon
Darling Ingredients
DAR
+$109M
2
PCTY icon
Paylocity
PCTY
+$41.6M
3
ON icon
ON Semiconductor
ON
+$40.9M
4
ALB icon
Albemarle
ALB
+$35.3M
5
LLY icon
Eli Lilly
LLY
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 33.48%
2 Healthcare 19.41%
3 Financials 10.89%
4 Industrials 10.11%
5 Consumer Discretionary 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OWL icon
676
Blue Owl Capital
OWL
$19.7B
$1.57M 0.01%
83,100
JLL icon
677
Jones Lang LaSalle
JLL
$17B
$1.56M 0.01%
8,018
AYI icon
678
Acuity Brands
AYI
$10.8B
$1.56M 0.01%
5,800
AXTA icon
679
Axalta
AXTA
$7.93B
$1.56M 0.01%
45,300
LEA icon
680
Lear
LEA
$8.16B
$1.55M 0.01%
10,700
BECN
681
DELISTED
Beacon Roofing Supply, Inc.
BECN
$1.54M 0.01%
15,695
WLK icon
682
Westlake Corp
WLK
$10.2B
$1.53M 0.01%
10,000
-2,900
-22% -$408K
EXEL icon
683
Exelixis
EXEL
$12.5B
$1.53M 0.01%
64,366
BERY
684
DELISTED
Berry Global Group, Inc.
BERY
$1.52M 0.01%
27,399
ESTC icon
685
Elastic
ESTC
$8.94B
$1.51M 0.01%
15,100
BIO icon
686
Bio-Rad Laboratories Class A
BIO
$9.66B
$1.51M 0.01%
4,372
GNTX icon
687
Gentex
GNTX
$4.99B
$1.51M 0.01%
41,766
ARW icon
688
Arrow Electronics
ARW
$10.6B
$1.5M 0.01%
11,600
OMF icon
689
OneMain Financial
OMF
$7.51B
$1.5M 0.01%
29,381
+10,500
+56% +$502K
THO icon
690
Thor Industries
THO
$4.11B
$1.48M 0.01%
12,623
+4,200
+50% +$481K
IONS icon
691
Ionis Pharmaceuticals
IONS
$9.28B
$1.47M 0.01%
33,911
+6,900
+26% +$329K
LNTH icon
692
Lantheus
LNTH
$6.59B
$1.46M 0.01%
23,500
+10,300
+78% +$606K
BILL icon
693
BILL Holdings
BILL
$5.11B
$1.46M 0.01%
21,256
+2,700
+15% +$189K
GLBE icon
694
Global E Online
GLBE
$7.09B
$1.46M 0.01%
40,140
GMED icon
695
Globus Medical
GMED
$11.5B
$1.46M 0.01%
27,197
BWA icon
696
BorgWarner
BWA
$13.8B
$1.46M 0.01%
41,931
MKTX icon
697
MarketAxess Holdings
MKTX
$5.72B
$1.46M 0.01%
6,644
FCN icon
698
FTI Consulting
FCN
$4.24B
$1.46M 0.01%
6,923
+900
+15% +$181K
CIEN icon
699
Ciena
CIEN
$62.7B
$1.45M 0.01%
29,362
STAG icon
700
STAG Industrial
STAG
$7.12B
$1.44M 0.01%
37,502

Similar funds

Handelsbanken Fonder's Q1 2024 Portfolio in Review

As of Q1 2024, Handelsbanken Fonder held 1,586 positions worth $23.2B, up 13% from $20.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Handelsbanken Fonder deployed $745M of net new capital in Q1 2024, opening 30 new positions and adding to 559 existing holdings. Its largest new stake was Arcadium Lithium plc: 4,193,903 shares worth $18.1M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Darling Ingredients, an estimated $109M trimmed.

  • Handelsbanken Fonder's largest Q1 2024 buy was Arcadium Lithium plc: 4,193,903 shares worth $18.1M.
  • Handelsbanken Fonder added most to Meta Platforms (Facebook) in Q1 2024, an estimated $113M increase.
  • Handelsbanken Fonder's biggest Q1 2024 reduction was Darling Ingredients, cutting an estimated $109M.
  • Handelsbanken Fonder fully exited Splunk Inc in Q1 2024, selling an estimated $13.1M.
  • Handelsbanken Fonder's ten largest holdings make up 29% of its $23.2B portfolio in Q1 2024.
  • Handelsbanken Fonder opened 30 new positions and closed 24 in Q1 2024.
  • Handelsbanken Fonder's portfolio value rose 13% quarter-over-quarter to $23.2B.

Based on Handelsbanken Fonder's 13F filing for Q1 2024, filed 13 May 2024.